Correction: IDO1 and IDO2 Non-Synonymous Gene Variants: Correlation with Crohn's Disease Risk and Clinical Phenotype.

Correction: IDO1 and IDO2 Non-Synonymous Gene Variants: Correlation with Crohn's Disease Risk and Clinical Phenotype.

Bibliographic Details
Main Authors:	Alexander Lee, Navya Kanuri, Yuanhao Zhang, Gregory S Sayuk, Ellen Li, Matthew A Ciorba
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4501741?pdf=render

Similar Items

IDO1 and IDO2 non-synonymous gene variants: correlation with crohn's disease risk and clinical phenotype.
by: Alexander Lee, et al.
Published: (2014-01-01)

Impact of IDO1 and IDO2 on the B Cell Immune Response
by: Lauren M. F. Merlo, et al.
Published: (2022-04-01)

Tér–idő–társadalom
by: Kovács Zoltán
Published: (1991-06-01)

Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses
by: Lauren M. F. Merlo, et al.
Published: (2020-08-01)

IDO2 in immunomodulation and autoimmunity
by: George ePrendergast, et al.
Published: (2014-11-01)

Tarikan pakaian Vintage Ido
by: Zahrom, Basir
Published: (2014)

Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans
by: Valerio Napolioni, et al.
Published: (2019-05-01)

IDO activation, inflammation and musculoskeletal disease
by: Ogbechi, J, et al.
Published: (2019)

Kvantitatív drámaelemzés és az idő
by: Botond Szemes, et al.
Published: (2023-12-01)

Pasture vegetation near the village of Iđoš
by: Knežević Aleksa S., et al.
Published: (2014-01-01)

Társadalmi viszonyok, tér és idő
by: Urry John, et al.
Published: (1990-09-01)

Single-nucleotide polymorphisms and activities of indoleamine 2,3-dioxygenase isoforms, IDO1 and IDO2, in tuberculosis patients
by: Tingming Cao, et al.
Published: (2022-01-01)

Exploitation of the IDO Pathway in the Therapy of Rheumatoid Arthritis.
by: Williams, R
Published: (2013)

IDO and kunurenine metabolites in peripheral and CNS disorders
by: Huang, Y-S, et al.
Published: (2020)

IDO Targeting in Sarcoma: Biological and Clinical Implications
by: Imane Nafia, et al.
Published: (2020-03-01)

On the nonredundant roles of TDO2 and IDO1
by: Paolo ePuccetti
Published: (2014-10-01)

¿Cómo ha ido evolucionando la revista?
by: María Carolina Cabrera Schulmeyer
Published: (2019-09-01)

Trial watch: IDO inhibitors in cancer therapy
by: Julie Le Naour, et al.
Published: (2020-01-01)

IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
by: Yi-Shu Huang, et al.
Published: (2020-03-01)

Immunological relevance of the coevolution of IDO1 and AHR
by: Francisco Javier Quintana, et al.
Published: (2014-10-01)

Unbalanced IDO1/IDO2 Endothelial Expression and Skewed Keynurenine Pathway in the Pathogenesis of COVID-19 and Post-COVID-19 Pneumonia
by: Marco Chilosi, et al.
Published: (2022-06-01)

An adverse tumor-protective effect of IDO1 inhibition
by: Kenski, JCN, et al.
Published: (2023)

Az európai idős lakosság szokásaiban jelentkező eltérések
by: Bella Klaudia Máténé, et al.
Published: (2020-09-01)

The IDO Metabolic Trap Hypothesis for the Etiology of ME/CFS
by: Alex A. Kashi, et al.
Published: (2019-07-01)

IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity
by: Lauren M.F. Merlo, et al.
Published: (2016-11-01)

IDO/kynurenine pathway in cancer: possible therapeutic approaches
by: Eslam E. Abd El-Fattah
Published: (2022-08-01)

Current Challenges for IDO2 as Target in Cancer Immunotherapy
by: Giada Mondanelli, et al.
Published: (2021-04-01)

IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity
by: Lauren M.F. Merlo, et al.
Published: (2016-01-01)

IDO Expression in Cancer: Different Compartment, Different Functionality?
by: Annabel Meireson, et al.
Published: (2020-09-01)

New insights into IDO biology in bacterial and viral infections
by: Susanne Viktoria Schmidt, et al.
Published: (2014-08-01)

Activities of plasma indoleamine-2, 3-dioxygenase (IDO) enzyme in Nigerian patients with lung diseases: basis for tryptophan supplementation or IDO inhibitor use
by: Ganiyu Olatunbosun Arinola, et al.
Published: (2023-01-01)

IDO1, FAT10, IFI6, and GILT Are Involved in the Antiretroviral Activity of γ-Interferon and IDO1 Restricts Retrovirus Infection by Autophagy Enhancement
by: Yoshinao Kubo, et al.
Published: (2022-07-01)

Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG35-55-induced experimental autoimmune encephalomyelitis
by: Lisa A. Wetzel, et al.
Published: (2020-08-01)

Cancer immunotherapy by targeting IDO1/TDO and their downstream effectors
by: Michael ePlatten, et al.
Published: (2015-01-01)

Modulating the immune system by amino acid depletion - IDO and beyond
by: Vallius, L
Published: (2011)

Aiki and Ido Swimming. Connections Between Swimming and Martial Arts
by: Wojciech J. Cynarski
Published: (2024-03-01)

Aproximació a la partícula "idò", valors i melodies
by: Ignasi Mascaró
Published: (2014-02-01)

The philosophy of martial arts – the example of the concept of <i>Ido</i>
by: Wojciech J. Cynarski
Published: (2017-11-01)

Targeting the IDO1 pathway in cancer: from bench to bedside
by: Ming Liu, et al.
Published: (2018-08-01)

Socioeconomic correlates of catfish production status in Ido Local Government Area of Oyo State, Nigeria
by: Oke Folasade Olukemi, et al.
Published: (2021-01-01)